Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Moody's
MCO
5
Jefferies Financial
JEF
CN Stock MarketDetailed Quotes
688505 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd.
- 7.83
- +0.22+2.89%
Market Closed Apr 30 15:00 CST
8.12BMarket Cap200.77P/E (TTM)
7.88High7.66Low35.38KlotVolume7.68Open7.61Pre Close27.51MTurnover0.50%Turnover Ratio206.05P/E (Static)1.04BShares10.2952wk High3.52P/B5.56BFloat Cap6.0252wk Low9.13Limit Up710.57MShs Float42.07Historical High6.09Limit Down2.89%Amplitude6.02Historical Low0.09Dividend TTM7.78Avg Price14.92KlotAsk1.15%Div YieldTTM100Lot Size20.15KlotBid
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -36.98%777.32M | -11.67%1.06B | -16.41%1.04B | -0.70%1.22B | 38.89%1.23B | -7.24%1.2B | 0.43%1.24B | 2.03%1.23B | -22.76%888.01M | 6.65%1.29B |
| Transactional financial assets | --280M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --190M | ---- |
| Notes receivable and accounts receivable | -17.64%440.8M | -24.26%469.96M | -19.35%524.88M | -23.54%565.88M | -20.73%535.19M | -8.63%620.49M | -7.61%650.8M | 42.14%740.09M | 8.50%675.14M | 0.99%679.12M |
| -Notes receivable | 44.53%120.22M | -30.87%120.47M | -0.55%125.95M | 17.41%117.53M | -36.42%83.18M | 0.88%174.26M | 7.22%126.65M | 21.73%100.1M | 27.68%130.83M | 46.23%172.74M |
| -Accounts receivable | -29.08%320.57M | -21.68%349.49M | -23.89%398.93M | -29.94%448.35M | -16.96%452.01M | -11.88%446.22M | -10.60%524.15M | 45.96%639.99M | 4.72%544.32M | -8.65%506.38M |
| Other receivables (including interest and dividends) | -40.90%1.98M | -29.65%2.49M | -30.91%3.3M | -23.39%3.63M | -40.90%3.36M | -27.33%3.54M | 0.12%4.77M | 5.65%4.73M | 24.70%5.68M | 22.99%4.87M |
| -Other receivable | ---- | -29.65%2.49M | ---- | -23.39%3.63M | ---- | -27.33%3.54M | ---- | 5.65%4.73M | ---- | 22.99%4.87M |
| Advance payment | 53.89%17.81M | 471.48%24.75M | 445.41%34.48M | 127.87%20.38M | 70.43%11.57M | -75.92%4.33M | -53.01%6.32M | -10.83%8.95M | -26.59%6.79M | 202.46%17.99M |
| Inventories | -5.40%44.39M | 8.28%47.27M | 14.75%47.2M | 6.39%52.71M | -5.82%46.92M | 7.71%43.65M | 17.86%41.13M | 17.82%49.55M | 16.02%49.82M | 13.76%40.53M |
| Non-current assets due within one year | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --33.63M | --33.32M |
| Other current assets | 108.40%6.02M | 295.90%6.02M | 82.10%8.38M | -47.89%4.52M | -80.46%2.89M | -62.49%1.52M | 1,308.05%4.6M | 3,410.80%8.68M | 662.51%14.8M | 288.05%4.06M |
| Adjustment items of current assets | ---- | ---- | --1 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Total current assets | -14.45%1.57B | -14.05%1.61B | -15.04%1.66B | -8.49%1.87B | -1.64%1.83B | -9.65%1.87B | -2.25%1.95B | 14.52%2.04B | 1.81%1.86B | 7.33%2.07B |
| Non Current assets | ||||||||||
| Other equity investment | -10.16%8.35K | -30.03%10.58K | -95.29%17.21K | -93.39%24.24K | -96.96%9.29K | -97.50%15.13K | -24.34%365.25K | -68.78%366.68K | -80.90%305.36K | -70.48%604.24K |
| Long term receivable account | 69.55%1.63M | 69.55%1.63M | --991.22K | --991.22K | --958.5K | --958.5K | ---- | ---- | ---- | ---- |
| Fixed assets | ---- | 108.67%476.8M | ---- | 138.32%491.65M | ---- | 10.78%228.5M | ---- | -1.32%206.3M | ---- | -7.46%206.26M |
| Constru in process | ---- | -96.87%7.2M | ---- | -99.89%187.19K | ---- | 87.92%229.96M | ---- | 72.59%169.08M | ---- | 150.25%122.37M |
| Intangible assets | -21.47%65.22M | -20.50%68.65M | 27.32%74.32M | 33.72%79.57M | 36.63%83.06M | 38.56%86.35M | -29.48%58.37M | -29.21%59.5M | -29.61%60.79M | -29.54%62.32M |
| Development expenditure | ---- | ---- | -97.41%921.68K | -97.92%737.61K | -98.42%556.78K | ---- | 4.73%35.61M | 9.78%35.46M | 20.22%35.21M | 24.30%34.83M |
| Long deferred expense | -20.74%6.77M | -18.08%9.28M | -19.61%5.08M | 9.92%7.62M | 3.50%8.54M | 37.06%11.32M | -21.86%6.33M | -14.32%6.93M | -1.61%8.26M | 2.01%8.26M |
| Deferred tax assets | 30.92%133.28M | 32.13%133.28M | 8.90%101.54M | 8.57%99.4M | 10.03%101.8M | 17.43%100.87M | 8.35%93.25M | -12.35%91.56M | 7.49%92.52M | 8.43%85.9M |
| Usufruct assets | 21.59%17.87M | 15.79%19.54M | -34.37%11.03M | -32.66%12.68M | -30.50%14.69M | -26.26%16.87M | -32.53%16.81M | -30.14%18.83M | -25.00%21.14M | -24.09%22.88M |
| Other non current assets | -90.59%4.27M | -86.92%5.87M | -90.31%7.46M | -93.03%7.01M | -55.43%45.34M | -22.09%44.89M | 98.60%77.01M | 217.70%100.51M | 256.38%101.73M | 193.35%57.62M |
| Adjustment items of non current assets | ---- | ---- | --1 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Total non current assets | -2.96%962.7M | -2.73%979.72M | -2.57%970.35M | -0.89%979.09M | 0.56%992.03M | 11.08%1.01B | 9.03%995.93M | 7.64%987.88M | 11.71%986.47M | 6.28%906.82M |
| Total assets | -10.42%2.53B | -10.09%2.59B | -10.82%2.63B | -6.02%2.85B | -0.88%2.83B | -3.34%2.88B | 1.29%2.95B | 12.18%3.03B | 5.03%2.85B | 7.01%2.98B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | ---- | ---- | ---- | ---- | ---- | ---- | --100M | --100M | --101M | --101M |
| Notes payable and accounts payable | 19.09%8.8M | 32.48%10.67M | 69.03%12.87M | 56.68%13.87M | -25.45%7.39M | 8.39%8.05M | -11.81%7.61M | -33.67%8.85M | -29.46%9.91M | -9.00%7.43M |
| -Accounts payable | 19.09%8.8M | 32.48%10.67M | 69.03%12.87M | 56.68%13.87M | -25.45%7.39M | 8.39%8.05M | -11.81%7.61M | -33.67%8.85M | -29.46%9.91M | -9.00%7.43M |
| Contract liabilities | 884.44%3.11M | 3,099.02%8.34M | -1.73%366.31K | 88.51%481.05K | 11.47%316.09K | -15.60%260.74K | 60.33%372.78K | 44.25%255.19K | -69.71%283.57K | -72.34%308.92K |
| Salaries payable | 34.68%1.3M | -26.60%18.41M | -91.91%1.65M | -17.47%16.72M | -52.65%962.78K | -9.64%25.08M | -13.86%20.37M | 540.29%20.26M | -61.25%2.03M | -23.93%27.76M |
| Taxs payable | 2.71%8.28M | -34.76%7.96M | -86.25%1.37M | 55.85%14.56M | 276.55%8.06M | 26.93%12.2M | -58.88%9.96M | -0.69%9.34M | -84.87%2.14M | -67.66%9.61M |
| Other payable (including interest and dividends) | -62.36%162.35M | -55.99%199.38M | -41.97%246.49M | -17.97%432.36M | 2.83%431.37M | -12.70%453.06M | -26.43%424.75M | 8.25%527.09M | -0.02%419.48M | 16.89%518.97M |
| -Dividend payable | ---- | ---- | --2.16M | --72.56M | ---- | ---- | ---- | ---- | ---- | --1.34M |
| -Other payable | ---- | -55.99%199.38M | ---- | ---- | ---- | -12.48%453.06M | ---- | --527.09M | ---- | --517.63M |
| Non current liabilities due within one year | 13.90%5.59M | -3.65%6.1M | -54.45%3.01M | -60.05%3.24M | -37.00%4.91M | -22.97%6.33M | -21.78%6.6M | -6.73%8.11M | -9.35%7.79M | -5.29%8.22M |
| Other current liabilities | 2.54%42.13K | 157.41%87.25K | -1.73%47.62K | 88.50%62.54K | 11.47%41.09K | -15.60%33.9K | 60.33%48.46K | 44.26%33.18K | 59.75%36.87K | -13.76%40.16K |
| Total current liabilities | -58.18%189.47M | -50.31%250.95M | -53.35%265.8M | -28.59%481.3M | -16.52%453.05M | -25.00%505.02M | -11.33%569.71M | 29.18%673.95M | 17.32%542.67M | 27.48%673.34M |
| Current liabilities | ||||||||||
| Long term deferred income | 1,208.66%20.59M | 636.13%15.85M | -98.57%414.83K | -96.78%994.08K | -95.12%1.57M | -93.68%2.15M | -18.84%29.1M | -17.94%30.91M | -17.33%32.23M | -16.56%34.04M |
| Lease liabilities | 33.12%13.14M | 31.73%14.43M | -20.55%8.29M | -19.70%8.98M | -26.71%9.87M | -29.78%10.95M | -39.59%10.43M | -43.85%11.19M | -35.45%13.47M | -30.94%15.6M |
| Total non current liabilities | 194.75%33.73M | 131.00%30.27M | -77.99%8.7M | -76.30%9.98M | -74.96%11.44M | -73.60%13.11M | -25.59%39.53M | -26.90%42.09M | -23.64%45.7M | -21.68%49.64M |
| Total liabilities | -51.95%223.2M | -45.72%281.23M | -54.94%274.5M | -31.39%491.27M | -21.05%464.49M | -28.34%518.12M | -12.42%609.24M | 23.60%716.04M | 12.63%588.37M | 22.21%722.99M |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%103.66M | 0.00%103.66M | 0.00%103.66M | 0.00%103.66M | 0.74%103.66M | 0.74%103.66M | 0.74%103.66M | 0.74%103.66M | -1.34%102.9M | -1.34%102.9M |
| Capital reserve funds | 0.02%1.29B | 0.02%1.29B | 0.39%1.29B | -0.00%1.29B | 5.20%1.29B | 5.25%1.29B | 0.02%1.29B | 1.80%1.29B | -2.93%1.23B | -3.17%1.23B |
| Surplus reserve funds | 0.00%52.15M | 0.00%52.15M | 0.00%52.15M | 0.00%52.15M | 0.00%52.15M | 0.00%52.15M | 0.00%52.15M | 0.00%52.15M | 0.00%52.15M | 0.00%52.15M |
| Retained profit | -5.78%867.42M | -5.83%864.75M | 1.32%911.49M | 4.34%916.22M | 3.33%920.66M | 4.09%918.31M | 15.17%899.58M | 23.98%878.12M | 8.50%891.03M | 8.08%882.24M |
| Other composite income | 4.23%-5.58M | 5.31%-5.55M | -14.03%-6.08M | -7.70%-5.72M | -5.07%-5.83M | -12.64%-5.86M | -1.48%-5.33M | -11.61%-5.31M | -22.89%-5.55M | -28.39%-5.2M |
| Shareholders equity without minority interests | -2.23%2.31B | -2.25%2.3B | 0.70%2.35B | 1.62%2.36B | 4.14%2.36B | 4.45%2.36B | 5.39%2.34B | 9.07%2.32B | 3.25%2.27B | 2.93%2.26B |
| Minority interests | -32.11%625.98K | -29.70%709.69K | -35.62%712.48K | 122.50%880.47K | 122.63%922K | 124.74%1.01M | 132.17%1.11M | -15.03%-3.91M | -17.34%-4.07M | -21.60%-4.08M |
| Total shareholder equity | -2.25%2.31B | -2.26%2.31B | 0.68%2.35B | 1.83%2.36B | 4.37%2.36B | 4.68%2.36B | 5.60%2.34B | 9.06%2.31B | 3.22%2.26B | 2.90%2.25B |
| Total liabilityies and equity | -10.42%2.53B | -10.09%2.59B | -10.82%2.63B | -6.02%2.85B | -0.88%2.83B | -3.34%2.88B | 1.29%2.95B | 12.18%3.03B | 5.03%2.85B | 7.01%2.98B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | -- | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts